Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab

We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibeeb, O'Sam, Vaze, Anagha, Gillies, Mark, Gray, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198777/
https://www.ncbi.nlm.nih.gov/pubmed/25349755
http://dx.doi.org/10.1155/2014/219792
_version_ 1782339785315057664
author Shibeeb, O'Sam
Vaze, Anagha
Gillies, Mark
Gray, Timothy
author_facet Shibeeb, O'Sam
Vaze, Anagha
Gillies, Mark
Gray, Timothy
author_sort Shibeeb, O'Sam
collection PubMed
description We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitreal bevacizumab and argon laser photocoagulation. The patient was then treated with intravitreal aflibercept injections, following which the macular oedema was completely resolved and his vision was significantly improved. Intravitreal aflibercept injection appears to improve vision and reduce persistent macular oedema secondary to type 1 IMT and demonstrated promising anatomical and visual outcomes.
format Online
Article
Text
id pubmed-4198777
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41987772014-10-27 Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab Shibeeb, O'Sam Vaze, Anagha Gillies, Mark Gray, Timothy Case Rep Ophthalmol Med Case Report We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitreal bevacizumab and argon laser photocoagulation. The patient was then treated with intravitreal aflibercept injections, following which the macular oedema was completely resolved and his vision was significantly improved. Intravitreal aflibercept injection appears to improve vision and reduce persistent macular oedema secondary to type 1 IMT and demonstrated promising anatomical and visual outcomes. Hindawi Publishing Corporation 2014 2014-10-01 /pmc/articles/PMC4198777/ /pubmed/25349755 http://dx.doi.org/10.1155/2014/219792 Text en Copyright © 2014 O'Sam Shibeeb et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shibeeb, O'Sam
Vaze, Anagha
Gillies, Mark
Gray, Timothy
Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title_full Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title_fullStr Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title_full_unstemmed Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title_short Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
title_sort macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198777/
https://www.ncbi.nlm.nih.gov/pubmed/25349755
http://dx.doi.org/10.1155/2014/219792
work_keys_str_mv AT shibeebosam macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab
AT vazeanagha macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab
AT gilliesmark macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab
AT graytimothy macularoedemainidiopathicmaculartelangiectasiatype1responsivetoafliberceptbutnotbevacizumab

Ejemplares similares